NHS Trust Admits 20 Women Had Unnecessary Mastectomies
Twenty women underwent unnecessary mastectomies and hundreds experienced documented clinical harm while receiving breast cancer care under the County Durham and Darlington Foundation Trust (CDDFT), according to admissions made by the NHS trust. The unfolding public health crisis, spanning treatment cases primarily reviewed between January 2023 and February 2025, has triggered active criminal investigations by Durham Police and the National Crime Agency alongside an urgent independent review.
- Out of 514 patient cases reviewed by CDDFT, the trust identified that 315 individuals suffered clinical harm, with 77 classified as significantly harmed and one known fatality recorded.
- The surgical decisions central to the review were overseen by Amir Bhatti, who served as the trust’s clinical lead for breast services from 2013 to 2024.
- External oversight reports from the Royal College of Surgeons and governance specialist Mary Aubrey flagged severe systemic failures, including a lack of multidisciplinary team review and financial incentives linked to outsourced private clinics.
The institutional failures center on flawed surgical planning, inadequate diagnostic protocols, and a breakdown in standard multidisciplinary team (MDT) oversight. According to a review by the Royal College of Surgeons (RCS) cited in coverage by the BBC, breast cancer cases at the trust were frequently omitted from proper MDT meetings. These collaborative forums—standardized across oncology to involve surgeons, radiologists, pathologists, and cancer specialists—are designed to challenge treatment plans and prevent unilateral surgical interventions.
Instead of multidisciplinary consensus, clinical decisions regarding major interventions like mastectomies were frequently made based on the unchallenged opinions of individual practitioners. Independent expert reviews indicated that the trust’s breast unit exhibited a high rate of repeated procedures, a low uptake of immediate breast reconstruction following mastectomies, and surgical operations that may have been executed too quickly. Furthermore, an investigation by governance specialist Mary Aubrey highlighted that outsourcing patient appointments to private clinics run by the lead consultant created financial incentives that posed a direct risk to clinical standards.
Patients have shared the devastating personal toll of these diagnostic and surgical errors. Denise Howarth, a 51-year-old patient from Consett, County Durham, was diagnosed with grade 1 cancer in 2023. After an initial lumpectomy, she underwent a full mastectomy, chemotherapy, and radiotherapy. In September 2025, she received notification from the NHS stating that she could have safely been offered a second lumpectomy instead of complete breast removal. “You put your trust in professional people,” Howarth stated. “To be so badly let down is something I’ll never be able to come to terms with.”
Another patient, Pam Brown from Durham, underwent a mastectomy in 2022 at Spire Hospital in Washington, where one of the outsourced private clinics operated under the oversight of consultant Amir Bhatti. While Brown’s medical review is ongoing, photographs of her surgical scarring were evaluated by former breast cancer surgeon Liz O’Riordan. O’Riordan described the scarring as awful and noted that she had never encountered comparable outcomes, stating that standard protocol would have necessitated immediate revision surgery. “You can’t put a breast back,” O’Riordan noted in reporting by the BBC. “These are lifelong disfigurements, and it’s horrific.”
In response to the mounting findings, Steve Russell, who recently assumed the role of CDDFT chief executive, issued an unreserved apology for the harm inflicted on patients. The trust has ended its payment-per-service arrangements with private diagnostic and surgical entities. Meanwhile, Amir Bhatti has been suspended from clinical practice while remaining employed by the trust on full pay, declining to comment on the specifics while proceedings remain ongoing. For patients seeking specialized clinical evaluations, navigating complex diagnostic pathways, or requiring advocacy in light of institutional failures, engaging with qualified independent medical experts and oncology second-opinion clinics remains a critical safeguard for patient safety.
The Department of Health and Social Care indicated that the trust is collaborating urgently with NHS England, the Care Quality Commission, and independent specialists to stabilize clinical governance. With potential expansions of the internal review threatening to reopen up to 10,000 historical medical records dating back to 2015, public health authorities face sustained scrutiny over how systemic oversight mechanisms failed vulnerable cancer patients.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.